Infographics - Precision Medicine Market

The global precision medicine market is estimated to be valued at USD 92.31 Bn in 2024 and is expected to exhibit a CAGR of 11.3% during the forecast period (2024-2031). Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. This approach allows doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, where disease treatment is a standardized approach for all people. Precision medicine integrates genetic information and molecular diagnostics to tailor medical treatments based on the individual characteristics of each patient. With greater knowledge of patients' genetic makeup, doctors can determine if certain medicines, lifestyle changes, or treatments will help or if different options may need to be considered depending on the individual. This allows researchers and healthcare providers to determine the safest treatment option tailored for each patient, leading to improved treatment outcomes. With continued research and development, precision medicine holds promise to transform healthcare through targeted disease prevention and treatment.

Market Dynamics:

The global precision medicine market is driven by the increasing demand for personalized healthcare, rise in R&D investments for precision therapeutics development, growing application of next-generation sequencing (NGS) in precision medicine, and surging demand for healthcare reduction. However, the lack of data interpretation & standardization and high cost of treatment are expected to restrain the market growth. Meanwhile, emerging economies offer high-growth opportunities for market players. Precision medicine approaches could help address several burgeoning healthcare challenges by offering targeted therapeutics with improved efficacy and reduced side-effects compared to conventional treatment methods. The growing adoption of companion diagnostics and inclusion of precision medicine in drug development activities also presents new opportunities.

Key Features of the Study:

This report provides an in-depth analysis of the global precision medicine market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global precision medicine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Intomics, GENinCode, NanoString, Tepnel Pharma Services Limited, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc, QIAGEN, Quest Diagnostics Incorporated, Medtronic, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, bioMérieux SA, F. Hoffmann-La Roche Ltd, Eli Lilly & Company, GlaxoSmithKline plc, Cepheid, AstraZeneca PLC, Myriad Genetics Inc., and Bristol-Myers Squibb Company
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global precision medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global precision medicine market.

Market Segmentation

Technology:
- Bioinformatics
- Gene Sequencing
- Precision Molecular Diagnostics
- Big Data Analytics
- Others
Application:
- Oncology
  - Breast Cancer
  - Lung Cancer
  - Prostate Cancer
  - Colorectal Cancer
  - Others
- Central Nervous System
- Hematology
- Immunology
- Respiratory
- Others
End User:
- Biopharmaceutical Companies
- Diagnostic Laboratories
- Academic & Research Institutions
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles:
- Intomics
- GENinCode
- NanoString
- Tepnel Pharma Services Limited
- Pfizer Inc.
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Merck & Co. Inc
- QIAGEN
- Quest Diagnostics Incorporated
- Medtronic
- Thermo Fisher Scientific Inc.
- Laboratory Corporation of America Holdings
- bioMérieux SA
- Hoffmann-La Roche Ltd
- Eli Lilly & Company
- GlaxoSmithKline plc
- Cepheid
- AstraZeneca PLC
- Myriad Genetics Inc.
- Bristol-Myers Squibb Company

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Technology
  - Market Snapshot, By Application
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Acquisitions and Partnerships Scenario
- Ongoing Developments
- Porter’s Analysis
- PEST Analysis
Global Precision Medicine Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
Global Precision Medicine Market, By Technology, 2019 – 2031, (US$ Billion)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Bioinformatics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Gene Sequencing
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Drug Discovery
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Precision Molecular Diagnostics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Big Data Analytics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
Global Precision Medicine Market, By Application, 2019 – 2031, (US$ Billion)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Oncology
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    - Breast Cancer
    - Lung Cancer
    - Prostate Cancer
    - Colorectal Cancer
    - Others
- Central Nervous System
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Hematology
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Immunology
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Respiratory
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
Global Precision Medicine Market, By Region, 2019 – 2031, (US$ Billion)
- - - Introduction
    - Market Share Analysis, By Region, 2024 and 2031 (%)
    - Y-o-Y Growth Analysis, For Regions, 2019–2031
    - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
    - UK
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (US$ Billion)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Intomics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GENinCode
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- NanoString
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Tepnel Pharma Services Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- QIAGEN
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Quest Diagnostics Incorporated
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Medtronic
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Thermo Fisher Scientific Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Laboratory Corporation of America Holdings
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- bioMérieux SA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategie
- F. Hoffmann-La Roche Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Eli Lilly & Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GlaxoSmithKline plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cepheid
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AstraZeneca PLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Myriad Genetics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bristol-Myers Squibb Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

PRECISION MEDICINE MARKET ANALYSIS

Precision Medicine Market

Need a Custom Report?

EXISTING CLIENTELE